NCT02591290
Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects prevention 4 completed NCT00355121
Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® prevention 2 completed NCT00937521
Safety and Immunogenicity in Dose-Ranging and Formulation-Finding Meningococcal B (MenB) Vaccine Study in 2-month-old Infants No drug interventions prevention 2 completed NCT00667602
Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers prevention 3 completed NCT01423084
Safety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years No drug interventions prevention 3 completed NCT01466387
A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults prevention 3 completed NCT00474487
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults No drug interventions prevention 3 completed NCT02842853
Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine prevention 3 completed NCT00384397
A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers prevention 3 completed NCT00856297
Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine prevention 3 completed NCT01192997
Comparison of Two Meningococcal ACWY Conjugate Vaccines prevention 2 / 3 completed NCT02500511
Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study No drug interventions Not Available Not Available completed NCT00310856
Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months) prevention 2 completed NCT01210885
Immunogenicity and Safety of Different rMenB Plus MenACWY Formulations in Adolescents No drug interventions prevention 2 completed NCT01148017
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine prevention 3 completed NCT00944034
Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12 No drug interventions prevention 2 / 3 completed NCT01367158
Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines prevention 2 completed NCT01453348
Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine prevention 3 completed NCT02842866
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older prevention 3 completed NCT02864927
Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea prevention 4 completed NCT00518180
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents No drug interventions prevention 3 completed NCT01434680
Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy Toddlers prevention 2 completed NCT01424644
A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents prevention 4 completed NCT02699840
Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation Not Available Not Available completed NCT00994695
Safety, Immunogenicity and Reactogenicity Trial of Mencevax ACW135 Vaccine No drug interventions prevention 2 completed NCT06226714
A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds prevention 3 active_not_recruiting NCT01339923
A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According to Different Immunization Schedules and to Healthy Children Aged 2 to 10 Years No drug interventions prevention 3 completed NCT01717638
Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1 No drug interventions prevention 3 completed NCT01239043
Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination prevention 2 completed NCT01897402
Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine No drug interventions prevention 2 completed NCT02633787
Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier treatment 4 completed NCT06131554
A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 Years prevention 3 active_not_recruiting NCT01478347
A Phase 3b Study to Assess the Safety of Novartis Meningococcal B Recombinant Vaccine When Administered in Healthy At-risk Adults No drug interventions prevention 3 completed NCT01274897
A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in Korea No drug interventions prevention 3 completed NCT02955797
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers prevention 3 completed NCT02919293
Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age No drug interventions prevention 1 / 2 unknown_status NCT06337071
A Study of the ACYW135 Meningococcal Polysaccharide Conjugate Vaccine No drug interventions prevention 2 not_yet_recruiting NCT01214837
Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life No drug interventions prevention 3 completed NCT00450437
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults No drug interventions prevention 3 completed NCT02481232
A Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate Vaccine No drug interventions prevention 1 unknown_status NCT01018732
A Study to Evaluate the Persistence and Immune Response to a Booster Dose of MenACWY No drug interventions prevention 2 completed NCT01482052
Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis No drug interventions prevention 1 completed NCT02752906
Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine prevention 3 completed NCT00874549
Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years prevention 1 / 2 completed NCT01519713
Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects prevention 3 completed NCT01894919
Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28 prevention 3 completed NCT00310817
Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months. No drug interventions prevention 2 completed NCT01148524
Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10 No drug interventions prevention 2 / 3 completed NCT03205358
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers prevention 2 completed NCT00483574
Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers prevention 3 completed NCT01732627
Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older No drug interventions prevention 2 completed NCT02199691
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents prevention 2 completed NCT00422292
Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers prevention 3 completed NCT00329901
Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years prevention 3 completed NCT02640404
Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam prevention 2 completed NCT03964012
Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5) prevention 3 completed NCT03077438
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years prevention 3 completed NCT01352793
A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years No drug interventions prevention 3 completed NCT03431675
Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018 prevention 4 withdrawn NCT00780806
Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults No drug interventions Not Available 1 / 2 completed NCT05229536
Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 35 Months No drug interventions prevention 2 completed NCT03295318
Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds prevention 2 completed NCT00314041
Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants No drug interventions prevention 2 completed NCT03433482
A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age prevention 2 completed NCT02878291
Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months No drug interventions prevention 1 unknown_status NCT04689191
A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine No drug interventions prevention 3 unknown_status NCT04707391
Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine prevention 3 completed NCT04665791
A Human Controlled Infection Study With Neisseria Lactamica in Malian Adults No drug interventions basic_science Not Available unknown_status NCT00798304
Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants No drug interventions prevention 2 terminated NCT00443846
RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016) prevention 3 completed NCT00879814
Study Evaluating Safety And Tolerability Of Meningococcal B Rlp2086 Vaccine In Healthy Adults No drug interventions prevention 1 completed NCT00297687
Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults No drug interventions prevention 1 completed NCT06113198
A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age No drug interventions prevention 4 not_yet_recruiting NCT00808028
A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents No drug interventions prevention 2 completed NCT00161928
Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants prevention 3 completed NCT03824093
High and Low Resource Interventions to Promote HPV Vaccines No drug interventions health_services_research Not Available completed NCT03205371
Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers prevention 3 completed NCT03587207
Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years prevention 2 completed NCT05087056
Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents No drug interventions prevention 2 active_not_recruiting NCT05252715
Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months No drug interventions prevention 3 active_not_recruiting NCT03493919
A Sourcing Study to Collect Human Blood Samples From Healthy Adults other 4 completed NCT03378258
Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA. No drug interventions Not Available Not Available completed NCT03682939
Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population other 4 unknown_status NCT03549325
A Study Assessing Colonisation & Immunogenicity After Nasal Inoculation With N. Lactamica and Eradication on Day 4 or 14 No drug interventions prevention Not Available unknown_status NCT00474526
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants prevention 3 completed NCT04689165
A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine No drug interventions prevention 3 unknown_status NCT02724046
Ciprofloxacin for the Prevention of Meningococcal Meningitis prevention 4 completed NCT04685850
Long-term Sequelae of Childhood Meningitis and Meningococcal Purpura Fulminans No drug interventions Not Available Not Available recruiting